Literature DB >> 35244581

[Translated article] Oral Findings in Patients With COVID-19.

M Villarroel-Dorrego1, L Chacón2, R Rosas2, V Barrios2, Y Pernía2, H Vélez2.   

Abstract

The aim of this study was to describe oral lesions in a group of patients with COVID-19. We recruited 55 patients, 25 women (45.5%) and 30 men (54.5%), aged between 1 and 89 years with confirmed COVID-19 at different stages of severity. After obtaining informed consent, we examined their mouths and recorded clinical findings. Forty percent of the patients had at least 1 oral lesion. The most common lesions were candidiasis and ulcers (7 patients each); 2 patients had enanthems. Geographic tongue and caviar tongue were also observed. Altered taste, dry mouth, and painful/burning mouth were noted in 60%, 27.3%, and 36.4% of patients, respectively. Oral mucosal alterations and lesions were prevalent in this series of COVID-19 patients. Altered taste and a painful/burning mouth were common symptoms.
Copyright © 2022. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  COVID-19; Coronavirus; Lesiones orales; Manifestaciones bucales; Oral lesions; Oral manifestations; SARS-COV-2; SARS-COV2

Year:  2022        PMID: 35244581      PMCID: PMC8893314          DOI: 10.1016/j.ad.2022.02.002

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  19 in total

1.  Letter to Editor: Oral lesions in a patient with Covid-19.

Authors:  C-D Soares; R-A Carvalho; K-A Carvalho; M-G Carvalho; O-P Almeida
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-07-01

2.  Oral cavity lesions as a manifestation of the novel virus (COVID-19).

Authors:  Reza Ansari; Mina Gheitani; Farrokh Heidari; Firouzeh Heidari
Journal:  Oral Dis       Date:  2020-07-10       Impact factor: 3.511

3.  Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease?

Authors:  Roberto Onner Cruz Tapia; Alberto Jose Peraza Labrador; Douglas Magno Guimaraes; Luciano Hermios Matos Valdez
Journal:  Spec Care Dentist       Date:  2020-09-03

4.  Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?

Authors:  Juliana Amorim Dos Santos; Ana Gabriela Costa Normando; Rainier Luiz Carvalho da Silva; Renata Monteiro De Paula; Allan Christian Cembranel; Alan Roger Santos-Silva; Eliete Neves Silva Guerra
Journal:  Int J Infect Dis       Date:  2020-06-09       Impact factor: 3.623

5.  Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?

Authors:  Thaís Bianca Brandão; Luiz Alcino Gueiros; Thayanara Silva Melo; Ana Carolina Prado-Ribeiro; Ana Cristina Froelich Alo Nesrallah; Gladys Villas Boas Prado; Alan Roger Santos-Silva; Cesar Augusto Migliorati
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2020-08-18

6.  Oral symptoms and lesions in SARS-CoV-2-positive patient.

Authors:  Ana Glavina; Dolores Biočina-Lukenda; Marinka Mravak-Stipetić; Jasenka Markeljević
Journal:  Oral Dis       Date:  2020-09-15       Impact factor: 4.068

Review 7.  Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases.

Authors:  Barbora Hocková; Abanoub Riad; Jozef Valky; Zuzana Šulajová; Adam Stebel; Rastislav Slávik; Zuzana Bečková; Andrea Pokorná; Jitka Klugarová; Miloslav Klugar
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

8.  Mucosal involvement in a COVID-19-positive patient: A case report.

Authors:  Filiz Cebeci Kahraman; Hülya Çaşkurlu
Journal:  Dermatol Ther       Date:  2020-07-03       Impact factor: 3.858

9.  Oral vesiculobullous lesions associated with SARS-CoV-2 infection.

Authors:  Carmen Martín Carreras-Presas; Juan Amaro Sánchez; Antonio Francisco López-Sánchez; Enric Jané-Salas; Maria Luisa Somacarrera Pérez
Journal:  Oral Dis       Date:  2020-05-29       Impact factor: 4.068

10.  Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.

Authors:  C D Soares; A Mosqueda-Taylor; M G F de Carvalho; O P de Almeida
Journal:  Br J Dermatol       Date:  2020-11-02       Impact factor: 11.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.